Details
Stereochemistry | ACHIRAL |
Molecular Formula | C15H17N3 |
Molecular Weight | 239.3156 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CC1=C(NC(=N)NC2=C(C)C=CC=C2)C=CC=C1
InChI
InChIKey=OPNUROKCUBTKLF-UHFFFAOYSA-N
InChI=1S/C15H17N3/c1-11-7-3-5-9-13(11)17-15(16)18-14-10-6-4-8-12(14)2/h3-10H,1-2H3,(H3,16,17,18)
Molecular Formula | C15H17N3 |
Molecular Weight | 239.3156 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: CHEMBL287 Sources: https://www.ncbi.nlm.nih.gov/pubmed/8027978 |
107.0 nM [Ki] |
PubMed
Title | Date | PubMed |
---|---|---|
Cocaine increases the endothelial release of immunoreactive endothelin and its concentrations in human plasma and urine: reversal by coincubation with sigma-receptor antagonists. | 1998 Aug 4 |
|
Effect of sigma ligands on the cocaine-induced convulsions in mice. | 1999 Nov-Dec |
|
Biperiden hydrochlorate ameliorates dystonia of rats produced by microinjection of sigma ligands into the red nucleus. | 2000 Nov |
|
Effects of AH-9700, (+)-pentazocine, DTG and oxybutynin on micturition in anesthetized rats with acetone-induced cystitis. | 2001 Aug 24 |
|
Pharmacology of [3H]R(+)-7-OH-DPAT binding in the rat caudate-putamen. | 2001 Jan |
|
N-alkyl substituted analogs of the sigma receptor ligand BD1008 and traditional sigma receptor ligands affect cocaine-induced convulsions and lethality in mice. | 2001 Jan 12 |
|
Pharmacological actions of AH-9700 on micturition reflex in anesthetized rats. | 2001 Jan 26 |
|
Agmatine and putrescine uptake in the human glioma cell line SK-MG-1. | 2001 Jun |
|
Conformationally restricted analogs of BD1008 and an antisense oligodeoxynucleotide targeting sigma1 receptors produce anti-cocaine effects in mice. | 2001 May 11 |
|
Novel spiropiperidines as highly potent and subtype selective sigma-receptor ligands. Part 1. | 2002 Jan 17 |
|
Identification and pharmacological characterization of a specific agmatine transport system in human tumor cell lines. | 2003 Dec |
|
Intrastriatal administration of sigma ligands inhibits basal dopamine release in vivo. | 2003 Dec |
|
Protein kinase C-dependent potentiation of intracellular calcium influx by sigma1 receptor agonists in rat hippocampal neurons. | 2003 Nov |
|
Sigma1 receptor antagonists attenuate antidepressant-like effect induced by co-administration of 1,3 di-o-tolylguanidine (DTG) and memantine in the forced swimming test in rats. | 2003 Nov-Dec |
|
Sigma-1 receptor activation prevents intracellular calcium dysregulation in cortical neurons during in vitro ischemia. | 2006 Dec |
|
Prenatal developmental toxicity study of the basic rubber accelerator, 1,3-di-o-tolylguanidine, in rats. | 2006 Nov |
|
sigma(2)-receptor ligand-mediated inhibition of inwardly rectifying K(+) channels in the heart. | 2007 Jul |
|
sigma-1 receptor modulation of acid-sensing ion channel a (ASIC1a) and ASIC1a-induced Ca2+ influx in rat cortical neurons. | 2008 Nov |
Patents
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 17:57:15 GMT 2023
by
admin
on
Fri Dec 15 17:57:15 GMT 2023
|
Record UNII |
LL2P01I17O
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Common Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
97-39-2
Created by
admin on Fri Dec 15 17:57:15 GMT 2023 , Edited by admin on Fri Dec 15 17:57:15 GMT 2023
|
PRIMARY | |||
|
473
Created by
admin on Fri Dec 15 17:57:15 GMT 2023 , Edited by admin on Fri Dec 15 17:57:15 GMT 2023
|
PRIMARY | |||
|
7333
Created by
admin on Fri Dec 15 17:57:15 GMT 2023 , Edited by admin on Fri Dec 15 17:57:15 GMT 2023
|
PRIMARY | |||
|
202-577-6
Created by
admin on Fri Dec 15 17:57:15 GMT 2023 , Edited by admin on Fri Dec 15 17:57:15 GMT 2023
|
PRIMARY | |||
|
LL2P01I17O
Created by
admin on Fri Dec 15 17:57:15 GMT 2023 , Edited by admin on Fri Dec 15 17:57:15 GMT 2023
|
PRIMARY | |||
|
DTXSID2026606
Created by
admin on Fri Dec 15 17:57:15 GMT 2023 , Edited by admin on Fri Dec 15 17:57:15 GMT 2023
|
PRIMARY | |||
|
132023
Created by
admin on Fri Dec 15 17:57:15 GMT 2023 , Edited by admin on Fri Dec 15 17:57:15 GMT 2023
|
PRIMARY | |||
|
5307
Created by
admin on Fri Dec 15 17:57:15 GMT 2023 , Edited by admin on Fri Dec 15 17:57:15 GMT 2023
|
PRIMARY | |||
|
Ditolylguanidine
Created by
admin on Fri Dec 15 17:57:15 GMT 2023 , Edited by admin on Fri Dec 15 17:57:15 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
SALT/SOLVATE -> PARENT |